Cargando…

Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic

BACKGROUND: Genomic studies of high-grade/progressive meningiomas have reported a heterogeneous mutation spectrum, identifying few recurrently mutated genes. Most studies have been underpowered to detect genomic subclasses of aggressive meningiomas due to relatively small number of available samples...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Erik A., Santagata, Sandro, Wakimoto, Hiroaki, Shankar, Ganesh M., Barker, Fred G., Sharaf, Radwa, Reddy, Abhinav, Spear, Phoebe, Alexander, Brian M., Ross, Jeffrey S., Brastianos, Priscilla K., Cahill, Daniel P., Ramkissoon, Shakti H., Juratli, Tareq A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580027/ https://www.ncbi.nlm.nih.gov/pubmed/33087175 http://dx.doi.org/10.1186/s40478-020-01040-2

Ejemplares similares

Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord
por: Hua, Lingyang, et al.
Publicado: (2022)

The Role of Merlin/NF2 Loss in Meningioma Biology
por: Lee, Sungho, et al.
Publicado: (2019)

A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4
por: Williams, Erik A., et al.
Publicado: (2023)

Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling
por: Mei, Yu, et al.
Publicado: (2017)

Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis
por: Bachir, Suha, et al.
Publicado: (2021)

Molecular landscapes of longitudinal NF2 /22q and non‐NF2 /22q meningiomas show different life histories
por: Ng, Ho‐Keung, et al.
Publicado: (2022)

Group I Paks as therapeutic targets in NF2-deficient meningioma
por: Chow, Hoi-Yee, et al.
Publicado: (2015)

The Prognostic Value of Methylation Signatures and NF2 Mutations in Atypical Meningiomas
por: Meta, Rahmina, et al.
Publicado: (2021)

The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis
por: Gregory, Grace E, et al.
Publicado: (2023)

Sporadic multiple meningiomas harbor distinct driver mutations
por: Juratli, Tareq A., et al.
Publicado: (2021)

Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients
por: Nunes, Fabio P., et al.
Publicado: (2013)

Molecular Cytogenetic Study of the NF2 Gene Deletion in Meningioma in Sudanese Patients
por: AbdElmontalab, Farah Y, et al.
Publicado: (2013)

Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas
por: Agnihotri, Sameer, et al.
Publicado: (2017)

Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma
por: Mathew Thomas, Vinay, et al.
Publicado: (2019)

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas
por: Sun, Shuchen, et al.
Publicado: (2022)

Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations
por: Williams, Erik A., et al.
Publicado: (2020)

Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas
por: Tabernero, MariaDolores, et al.
Publicado: (2013)

NF2 alteration in mesothelioma
por: Sekido, Yoshitaka, et al.
Publicado: (2023)

Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma?
por: Evans, D. Gareth R., et al.
Publicado: (2022)

Mass Spectrometric Study of NF(2), NF(3), N(2)F(2), and N(2)F(4)
por: Herron, John T., et al.
Publicado: (1961)

Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma
por: Laraba, Liyam, et al.
Publicado: (2022)

NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas
por: Sakai, Yu, et al.
Publicado: (2022)

NF45 and NF90/NF110 coordinately regulate ESC pluripotency and differentiation
por: Ye, Julia, et al.
Publicado: (2017)

In Reply: A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas
por: Fujio, Shingo, et al.
Publicado: (2019)

Oncogenic Role of Merlin/NF2 in Glioblastoma
por: Guerrero, Paola A., et al.
Publicado: (2014)

Brainstem ischemic syndrome in juvenile NF2
por: Henson, John W., et al.
Publicado: (2020)

Vestibular dysfunction in NF2–related schwannomatosis
por: Madhani, Amsal S, et al.
Publicado: (2023)

The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations
por: Deng, Jiaojiao, et al.
Publicado: (2020)

Inducible expression of immediate early genes is regulated through dynamic chromatin association by NF45/ILF2 and NF90/NF110/ILF3
por: Wu, Ting-Hsuan, et al.
Publicado: (2019)

Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients
por: Bianchessi, Donatella, et al.
Publicado: (2020)

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
por: Hua, Lingyang, et al.
Publicado: (2020)

Mutually Exclusive Roles of SHARPIN in Integrin Inactivation and NF-κB Signaling
por: De Franceschi, Nicola, et al.
Publicado: (2015)

Non-perturbative renormalization of tensor currents: strategy and results for $N_f = 0$ and $N_f = 2$ QCD
por: Pena, Carlos, et al.
Publicado: (2017)

NfL and pNfH are increased in Friedreich’s ataxia
por: Hayer, Stefanie Nicole, et al.
Publicado: (2020)

Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice
por: Szulzewsky, Frank, et al.
Publicado: (2022)

Natural History of Meningioma Development in Mice Reveals: A Synergy of Nf2 and p16 (Ink4a) Mutations
por: Kalamarides, Michel, et al.
Publicado: (2007)

Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus
por: Hansson, Caisa M, et al.
Publicado: (2007)

Radiologically Indistinguishable Contiguous Meningioma and Schwannoma in the Same Cerebellopontine Angle in a Patient with NF2: Case Report and Literature Review
por: Munjal, Satyashiva, et al.
Publicado: (2018)

Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells
por: Wang, Jiapeng, et al.
Publicado: (2021)

Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK
por: Chang, Long-Sheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fporn9kkpefeahqk9dmau980n6